2018 Annual Meeting Program

49th Annual Meeting

September 7 - 9, 2018
Hilton Inverness Hotel and Conference Center

note: The program is confirmed 30 days prior to the event.

[button style="dark" size="small" type="border" link="#"]Download Program[/button]

Friday, September 7
Time Event Location
3:00 pm - 6:00 pm CHECK-IN and REGISTRATION Location
6:00 pm Welcome Reception Location
7:00 pm Welcome by PRS President Jeff Reese MD and dinner Location
8:00pm-8:45  pm Mead Johnson Nutrition Lecturer
Jeff Alberts
Title: "NASA and Reproduction in Space"
Moderator: Name
Location
8:45pm - 9:00pm Questions and Answers Location
Saturday, September 7
Time Event Location
6:45am - 7:45 am BREAKFAST Location
8:00 am - 8:45am Vanderbilt Lecturer
Sylain Chemtob
Title: Discovery of new IL-1 Receptor - Modulator - prevention of preterm labor and preservation of fetal integrity
Moderator: Member
Location
8:45am - 9:00am Questions and Answers Location
9:00am - 9:20am Mead Johnson Nutrition Early Career Speaker
Speaker
Title:  xxx
Moderator: Member
Location
9:20am - 9:30am Questions and Answers Location
9:30am - 9:50am Mead Johnson Nutrition Early Career Speaker
Speaker
Title:  xxx
Moderator: Member
Location
9:50am - 10:00am Questions and Answers Location
10:00 am - 10:30am BREAK Location
10:30 am - 11:15am Abbott Nutrition Lecturer
David Keefe
Title:3-parent IVF Embryos
Moderator: Member
Location
11:15am - 11:30am Questions and Answers Location
11:30 am- 11:50am Abbott Nutrition Early Career Speaker
Speaker

Title:xxx 
Moderator: Member
Location
11:50am - 12:00 noon Questions and Answers Location
12:00- 12:20pm Abbott Nutrition Early Career Speaker
Speaker

Title:xxx 
Moderator:
Location
12:20pm - 12:30pm Questions and Answers Location
12:30 pm 2:30pm LUNCH and free time Location
2:30 pm- 3:30pm BUSINESS MEETING Location
3:30pm - 4:15pm Liley Award Winner
Jane Harding DPhil FRCPC 
Title:Glucose levels in babies: Too high - too low - too variable - and does it matter?  In older children and adults-  the risks of hyper- and hypoglycaemia and their treatment are reasonably well understood.  In the newborn - all of these problems are much more common - but there is little evidence to support any of the current widely varying treatment approaches.  Recent research is beginning to reveal the long-term sequellae of early dysglycaemia - but there remains much uncertainty about causal relationships and appropriate management.  
Moderator
Location
4:15pm - 4:30pm Questions and Answers
4:30pm - 4:50 pm PSANZ-PRS MONT LIGGINS EARLY CAREER SPEAKER
Name
Title: xxx
Moderator:
Location
4:50 pm - 5:00 pm Questions and Answers location
5:00pm - 7:00pm Salsa making and beer tasting Location
7:00 pm - 8:00pm Dinner - Awards Location
7:45 pm Dinner and Trainee Awards Location
8:00pm- 8:45pm March of Dimes Lecturer
Richard Finkel 
Title: Genetic modulation strategies for Spinal Muscular Atrophy - current and future treatments
Moderator:
Location
8:45pm -  9:00pm Questions and Answers Location

 

Sunday, September 9
Time Event Location
6:45 am - 7:45am BREAKFAST Location
8:00 am - 8:45am NICHD LECTURER
Stephen Kingsmore MD DSC
Title: Perinatal Genomic Medicine.  Genetic diseases are the leading cause of death in infants - NICUs - PICUs and CVICUs.  Rapid whole genome sequencing (rWGS) can improve outcomes of infants in intensive care units by informing targeted treatments of genetic diseases.  The turnaround time of rWGs - from blood spot to provisional diagnosis - can be less than 20 hours.  Approximately 1/3 of symptomatic infants undergoing rWGs receive a diagnosis.  About 2/3 of infants diagnosed by rWGS have a consequent change in management - and about 1/3 have decreased mortality or morbidity.  It will be interesting to determine the impact of rWGS on perinatology
Moderator: Member
Location
8:45am - 9:00am Questions and Answers Location
9:00am - 9:45am Member Lecturer
David Aronoff MD FIDSA FAAM
Title: Paracrine Communication in Bacterial Chorioamnionitis
 Infection of the fetal membranes is a major cause of chorioamnionitis and its complications.  Despite this there are significant gaps in our understanding of how these membranes function to protect the developing fetus from infection and why they sometimes fail.  To better define the pathogenesis of bacterial chorioamnionitis we are deconstructing fetal membranes into component cell types (both immune and non-immune) and modeling for autocrine and paracrine responses to microbial threat agents using new systems such as organ-on-chip technologies. Moderator:
Location
9:45am - 10:00am Questions and Answers Location
10:00am - 10:15am Break Location
10:15am - 11:00am MEMBER LECTURER
Name
Title: xxx
Moderator: Member
Location
11:00am - 11:15am Questions and Answers Location
11:15am - 12:00 pm MEMBER LECTURER
Emily Su MD MS
Title: Fetoplacental Vessels ARNT Small Business.
Abnormal umbilical artery Doppler velocimetry in growth-restricted fetuses is an ominous finding that substantially increases risk for adverse perinatal and long-term outcomes.  Placentas from these pregnancies of demonstrate impaired fetoplacental angiogenesis.  In a model of an fetopental endothelial cells we have found that aryl hydrocarbon receptor nuclear traslocator (ARNT also known as HIF1-bet) is a major mediator of fetoplacental angiogenesis and its decreased expression in severe fetal growth restriction may impair proper development of placental vasculature.
Moderator: Member
Location
12:00pm - 12:15pm Questions and Answers Location
12:15pm CLOSING REMARKS - Adjournment - Lunch Location